New approach methodologies (NAMs) – such as advanced cell models and microtissues – are rapidly being adopted in the early stages of therapeutics development because they offer researchers more ...

Following the trend of other regulators, the European Medicines Agency (EMA) is taking steps to reduce the need for animal testing. The agency has issued a draft qualification opinion for a new ...

As regulatory authorities accelerate the use of New Approach Methodologies (NAMs), the drug discovery landscape is changing dramatically. This webinar explores how NAMs, immunology-driven platforms, ...

Using traditional animal models, drug development can take 10–15 years and cost more than US$2 billion per approved drug, with over 90% of drugs that succeed in animal tests failing in human trials.